Johnson & White Wealth Management LLC Makes New $675,000 Investment in UnitedHealth Group Incorporated (NYSE:UNH)

Johnson & White Wealth Management LLC purchased a new stake in UnitedHealth Group Incorporated (NYSE:UNHGet Rating) in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 1,428 shares of the healthcare conglomerate’s stock, valued at approximately $675,000.

A number of other hedge funds have also modified their holdings of UNH. Axiom Financial Strategies LLC purchased a new position in shares of UnitedHealth Group during the 1st quarter worth approximately $210,000. McGowan Group Asset Management Inc. boosted its stake in shares of UnitedHealth Group by 8.9% during the 1st quarter. McGowan Group Asset Management Inc. now owns 744 shares of the healthcare conglomerate’s stock worth $379,000 after purchasing an additional 61 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. lifted its stake in shares of UnitedHealth Group by 31.8% during the first quarter. Mirae Asset Global Investments Co. Ltd. now owns 250,196 shares of the healthcare conglomerate’s stock valued at $127,592,000 after buying an additional 60,300 shares during the period. MAS Advisors LLC lifted its stake in shares of UnitedHealth Group by 10.8% during the 1st quarter. MAS Advisors LLC now owns 463 shares of the healthcare conglomerate’s stock worth $241,000 after purchasing an additional 45 shares during the period. Finally, First Western Trust Bank acquired a new position in UnitedHealth Group in the first quarter valued at $875,000. 92.61% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity

In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,008 shares of the stock in a transaction on Friday, April 21st. The stock was sold at an average price of $484.58, for a total value of $488,456.64. Following the transaction, the executive vice president now directly owns 10,359 shares in the company, valued at approximately $5,019,764.22. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. In other news, EVP Erin Mcsweeney sold 1,008 shares of the company’s stock in a transaction that occurred on Friday, April 21st. The stock was sold at an average price of $484.58, for a total transaction of $488,456.64. Following the sale, the executive vice president now owns 10,359 shares in the company, valued at approximately $5,019,764.22. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CEO Andrew Witty sold 6,160 shares of the firm’s stock in a transaction on Thursday, April 27th. The shares were sold at an average price of $487.49, for a total value of $3,002,938.40. Following the sale, the chief executive officer now directly owns 86,564 shares of the company’s stock, valued at approximately $42,199,084.36. The disclosure for this sale can be found here. Insiders have sold 8,852 shares of company stock valued at $4,313,962 over the last three months. 0.35% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

A number of equities analysts have weighed in on UNH shares. Oppenheimer reaffirmed an “outperform” rating and set a $610.00 price target on shares of UnitedHealth Group in a research note on Monday, April 17th. Loop Capital upped their price target on UnitedHealth Group from $590.00 to $600.00 and gave the stock a “buy” rating in a report on Monday, April 17th. SVB Securities cut their target price on UnitedHealth Group from $625.00 to $560.00 in a research report on Wednesday, June 14th. JPMorgan Chase & Co. lowered their price target on UnitedHealth Group from $595.00 to $562.00 in a report on Tuesday, May 30th. Finally, Deutsche Bank Aktiengesellschaft decreased their target price on UnitedHealth Group from $627.00 to $564.00 in a research note on Friday, June 16th. One equities research analyst has rated the stock with a hold rating, fourteen have issued a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, UnitedHealth Group currently has a consensus rating of “Buy” and a consensus price target of $592.68.

UnitedHealth Group Price Performance

Shares of NYSE:UNH opened at $482.69 on Wednesday. UnitedHealth Group Incorporated has a twelve month low of $445.68 and a twelve month high of $558.10. The company has a market cap of $449.40 billion, a price-to-earnings ratio of 22.07, a PEG ratio of 1.40 and a beta of 0.68. The business has a 50 day moving average price of $484.23 and a 200 day moving average price of $491.07. The company has a quick ratio of 0.81, a current ratio of 0.81 and a debt-to-equity ratio of 0.71.

UnitedHealth Group (NYSE:UNHGet Rating) last posted its quarterly earnings data on Friday, April 14th. The healthcare conglomerate reported $6.26 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.24 by $0.02. The company had revenue of $91.93 billion for the quarter, compared to the consensus estimate of $89.77 billion. UnitedHealth Group had a net margin of 6.16% and a return on equity of 27.05%. The business’s revenue was up 14.7% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $5.49 EPS. Research analysts predict that UnitedHealth Group Incorporated will post 24.86 earnings per share for the current year.

UnitedHealth Group Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, June 27th. Shareholders of record on Monday, June 19th were given a $1.88 dividend. This represents a $7.52 annualized dividend and a yield of 1.56%. The ex-dividend date was Thursday, June 15th. This is a boost from UnitedHealth Group’s previous quarterly dividend of $1.65. UnitedHealth Group’s dividend payout ratio (DPR) is presently 34.39%.

UnitedHealth Group Profile

(Get Rating)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Featured Articles

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHGet Rating).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.